Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy

BACKGROUND: Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). However, recurrence within 2 years is observed in 30%–50% of patients, being a major cause of mortality. AIM: To construct and verify a non-invasive prediction model combining contrast-enhanced ultras...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Hai-Bin, Chen, Li-Hong, Huang, Yu-Jie, Feng, Si-Yi, Lin, Jian-Ling, Zeng, Yong-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409194/
https://www.ncbi.nlm.nih.gov/pubmed/34540956
http://dx.doi.org/10.12998/wjcc.v9.i24.7009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409194/
https://www.ncbi.nlm.nih.gov/pubmed/34540956
http://dx.doi.org/10.12998/wjcc.v9.i24.7009

Ejemplares similares